NWM — Immunoassay, Anti-Seizure Drug Class II
FDA product code NWM covers "Immunoassay, Anti-Seizure Drug", a Class II medical device regulated under 21 CFR 862.3350. Submissions are reviewed by the Clinical Toxicology panel. At least 5 recent 510(k) clearances have been granted under this product code.
Classification details
- Product Code
- NWM
- Device Class
- Class II
- Regulation Number
- 862.3350
- Submission Type
- 510(k)
- Review Panel
- TX
- Medical Specialty
- Clinical Toxicology
- Implant
- No
Definition
To aid in management of patients treated with anti-seizure drug.
Recent 510(k) clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K201089 | Ark Diagnostics | ARK Lacosamide Assay | Aug 5, 2021 |
| K091884 | Ark Diagnostics | ARK ZONISAMIDE ASSAY, ARK ZONISAMIDE CALIBRATOR, AND ARK ZONISAMIDE CONTRO… | Dec 9, 2009 |
| K083799 | Ark Diagnostics | TOPIRAMATE ASSAY, ARK TOPIRAMATE CALIBRATOR AND ARK TOPIRAMATE CONTROL, MODELS… | Apr 16, 2009 |
| K070645 | Seradyn | SERADYN QMS TOPIRAMATE | May 17, 2007 |
| K051211 | Seradyn | QMS ZONISAMIDE REAGENTS, CALIBRATORS AND CONTROLS | Nov 18, 2005 |